Molly Shoichet

University Professor

Professor Molly Shoichet holds the Tier 1 Canada Research Chair in Tissue Engineering at the University of Toronto. She served as Ontario’s first Chief Scientist in 2018 where she worked to enhance the culture of science. Dr. Shoichet has published over 650 papers, patents and abstracts and has given over 375 lectures worldwide. At the University of Toronto, she holds appointments in the Department of Chemical Engineering & Applied Chemistry, the Institute of Biomaterials & Biomedical Engineering and the Donnelly Centre. She currently leads a laboratory of 25 and has graduated close to 200 researchers. Her research is focused on drug and cell delivery strategies in the central nervous system (brain, spinal cord, retina) and 3D hydrogel culture systems to model cancer. Dr. Shoichet co-founded three spin-off companies (including AmacaThera), is actively engaged in translational research and science outreach. Dr. Shoichet is the recipient of many prestigious distinctions and the only person to be inducted into all three of Canada’s National Academies of Science, Engineering and Health Sciences. Professor Shoichet is a Fellow of the Royal Society (UK) and Foreign Member of the US National Academy of Engineering. She is an Officer of the Order of Canada and holds the Order of Ontario. Dr. Shoichet is a University Professor – the highest distinction of the University of Toronto, which is held by less than 2% of the faculty. Dr. Shoichet was the L’Oreal-UNESCO For Women in Science Laureate for North America in 2015 and won the Killam Prize in Engineering in 2017. Dr. Shoichet received her SB from the Massachusetts Institute of Technology (1987) and her PhD from the University of Massachusetts, Amherst in Polymer Science and Engineering (1992).


Mon, Sept 23


01:50pm - 02:10pm


Engineering Change with Molly Shoichet, Founder of Shoichet Labs

Join us at Elevate 2019!


02:50pm - 03:20pm


How Precision Medicine Will Revolutionize the Future of Healthcare with Molly Shoichet of Shoichet Labs, Dr. Ian Rogers (Lunenfield-Tanenbaum Research Institute), Dr. Elaine Chin & Drew Taylor of Acorn Labs moderated by Balaji Gopalan (Medstack)

The promise of personalized medicine is real. Innovations in biology are rapidly advancing the pace of medicine even well beyond the pace of what technologists used to describe with Moore's law. But how do we make sense of it all and how can we begin to distill the potential of precision medicine into actionable ideas that enable populations everywhere to capitalize on its promise?

There are no sessions for this stage on this day. Try another.

Tues, Sept 24

There are no sessions for this stage on this day. Try another.

Wed, Sept 25

There are no sessions for this stage on this day. Try another.

Thurs, Sept 26

There are no sessions for this stage on this day. Try another.